110 related articles for article (PubMed ID: 8017860)
1. Natural killer (NK) cell activity of women with gross cystic disease is inhibited in vitro by breast cyst fluid.
Ardizzoja M; Masera RG; Tacconis P; Sartori ML; Arisio R; Massobrio M; Angeli A
Anticancer Res; 1994; 14(2A):555-9. PubMed ID: 8017860
[TBL] [Abstract][Full Text] [Related]
2. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A
Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029
[TBL] [Abstract][Full Text] [Related]
3. [The autocrine-paracrine modulation of natural killer activity in man by peptides of the corticostatin-defensin family].
Masera RG; Gatti G; Bateman A; Solomon S; Sartori ML; Staurenghi A; Lazzero A; Griot G; Angeli A
Ann Ital Med Int; 1993; 8(2):80-5. PubMed ID: 8353023
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
5. In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients.
Fujimiya Y; Wagner RJ; Groveman S; Sielaff K; Kohsaka T; Nakayama M
Ther Immunol; 1995 Feb; 2(1):15-22. PubMed ID: 7553067
[TBL] [Abstract][Full Text] [Related]
6. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
7. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
[TBL] [Abstract][Full Text] [Related]
8. Altered circadian rhythms of natural killer (NK) cell activity in patients with autoimmune rheumatic diseases.
Masera RG; Carignola R; Staurenghi AH; Sartori ML; Lazzero A; Griot G; Angeli A
Chronobiologia; 1994; 21(1-2):127-32. PubMed ID: 7924633
[TBL] [Abstract][Full Text] [Related]
9. Ethanol and natural killer cells. II. Stimulation of human natural killer activity by ethanol in vitro.
Li F; Cook RT; Alber C; Rasmussen W; Stapleton JT; Ballas ZK
Alcohol Clin Exp Res; 1997 Sep; 21(6):981-7. PubMed ID: 9309305
[TBL] [Abstract][Full Text] [Related]
10. Circadian variations of interferon-induced enhancement of human natural killer (NK) cell activity.
Gatti G; Cavallo R; Sartori ML; Carignola R; Masera R; Delponte D; Salvadori A; Angeli A
Cancer Detect Prev; 1988; 12(1-6):431-8. PubMed ID: 3141053
[TBL] [Abstract][Full Text] [Related]
11. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
12. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of hyperthermia on natural cell-mediated cytotoxicity.
Fuggetta MP; Alvino E; Tricarico M; D'Atri S; Pepponi R; Prete SP; Bonmassar E
Anticancer Res; 2000; 20(3A):1667-72. PubMed ID: 10928089
[TBL] [Abstract][Full Text] [Related]
14. Effects of interferon-alpha and gamma on development of LAK activity from mononuclear cells in breast cancer patients.
Kamamura Y; Takahashi K; Komaki K; Monden Y
J Med Invest; 1998 Aug; 45(1-4):71-5. PubMed ID: 9864966
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic in vitro function in the lymphoproliferative disease of granular lymphocytes.
Zambello R; Chisesi T; Agostini C; Trentin L; Masciarelli M; Gasparotto G; Vespignani M; Casorati G; Foa R; Semenzato G
Clin Exp Immunol; 1987 Oct; 70(1):222-30. PubMed ID: 3121223
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
[TBL] [Abstract][Full Text] [Related]
17. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
Edwards BS; Hawkins MJ; Borden EC
Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
[TBL] [Abstract][Full Text] [Related]
19. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
Lebow LT; Jewett A; Bonavida B
J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130
[TBL] [Abstract][Full Text] [Related]
20. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer.
Konjević G; Spuzić I
Neoplasma; 1993; 40(2):81-5. PubMed ID: 8350959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]